Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks

The COVID-19 pandemic demands reassessment of head and neck oncology treatment paradigms. Head and neck cancer (HNC) patients are generally at high-risk for COVID-19 infection and severe adverse outcomes. Further, there are new, multilevel COVID-19-specific risks to patients, surgeons, health care w...

Descripción completa

Detalles Bibliográficos
Autores principales: Day, Andrew T., Sher, David J., Lee, Rebecca C., Truelson, John M., Myers, Larry L., Sumer, Baran D., Stankova, Lenka, Tillman, Brittny N., Hughes, Randall S., Khan, Saad A., Gordin, Eli A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136871/
https://www.ncbi.nlm.nih.gov/pubmed/32330858
http://dx.doi.org/10.1016/j.oraloncology.2020.104684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136871/
https://www.ncbi.nlm.nih.gov/pubmed/32330858
http://dx.doi.org/10.1016/j.oraloncology.2020.104684

Ejemplares similares